A Cancer Survivor Hoped To Work — Then She Lost Her Medicaid Disability Coverage
Taya Hailstone has been in remission from childhood Hodgkin lymphoma for five years. But the…
A Cancer Survivor Hoped To Work — Then She Lost Her Medicaid Disability Coverage
Taya Hailstone has been in remission from childhood Hodgkin lymphoma for five years. But the cancer’s lasting damage to her organs and nerves can make basic tasks, like loading a dishwasher, hard. Still, Montana’s health department decided last year that Hailstone is no longer eligible for low-cost disability health coverage through Medicaid. The department switched…
Rising Healthcare Costs Have Hit Georgia’s Most Conservative District. But Its Politics Are Unlikely To Change.
Amber Bates of Cohutta, Georgia, is one of thousands of people without health insurance in the 14th Congressional District, home to about 765,000 people in the northwestern corner of the state. She and her husband have not had health coverage for the past two years, Bates said, because their employment is unsteady and they earn…
FDA Regulation and the Dynamic Nature of AI
Dr. Brian Miller has seen medical technology regulation from every side — as a hospitalist, a former FDA official, and now an associate professor at Johns Hopkins University, where he leads a research group on market-driven approaches to FDA regulation and Medicare payment policy. In this episode, Chip talks with Miller about what happens when…
Latent Unveils Autonomous Agents to Streamline Medication Access
Latent’s AI-powered agents analyze patient data and automate administrative tasks such as prior authorizations
Nara Health Secures $14M for Third Party Administration Platform
Nara Health’s funding was led by Khosla Ventures, with participation from Long Journey Ventures and Superior Studios. The post Nara Health Secures $14M for Third Party Administration Platform appeared first on MedCity News.
Scholar Rock Drug Wins First-in-Class Approval in Rare Neuromuscular Disease
Scholar Rock’s Isembyld isn’t the only FDA-approved therapy for spinal muscular atrophy, but it is the first one that directly targets muscle tissue. Isembyld is the first commercial product for Scholar Rock, which is also evaluating the antibody in other rare muscle disorders. The post Scholar Rock Drug Wins First-in-Class Approval in Rare Neuromuscular Disease…
Shadow AI Is the Fastest Growing Force in Medicine, and Hospitals Are the Only Ones Who Can Control It
If trust, transparency, and accountability remain core values in medicine, AI governance cannot be left to improvisation. The post Shadow AI Is the Fastest Growing Force in Medicine, and Hospitals Are the Only Ones Who Can Control It appeared first on MedCity News.
Can AI Make Healthcare More Human?
This webinar explores how healthcare organizations can leverage AI not just for efficiency but to foster genuine patient engagement and strengthen human connections, emphasizing the importance of patient-centered care.
Correcting False Health Claims and Navigating AI-Generated Information — The Monitor
Corrections can improve the accuracy of people’s beliefs, but their impact may depend on reaching people before a claim has already spread widely. And research on AI-generated search results suggests that people may be less likely to visit the original sources behind AI-generated answers.
From Onboarding to Outcomes: The Privacy-First Identity Workflow for Pharma Marketing
[Sponsored] A new Experian playbook shows what privacy-first activation looks like in practice, from governed onboarding through partner-enabled measurement. The post From Onboarding to Outcomes: The Privacy-First Identity Workflow for Pharma Marketing appeared first on MedCity News.
